Next Science [ASX:NXS]

Snapshot

Public AU

Ownership

2012

Year founded

102

Employees

New South Wales, Australia

Head office

1 of 364

AU Rank

Healthcare

Sector

N/A

Sector rank

XBIO™ technology: Next Science's flagship product is its XBIO™ technology, a platform technology that can be used to develop a range of products to treat and prevent biofilm-based infections.
XPERIENCE: Designed for use in cleansing and removal of debris, including microorganisms from wounds.
BLASTX: Antimicrobial Wound Gel provides wound management by maintaining a moist wound environment, which is conducive to wound healing. While in place, the antimicrobial properties of the gel inhibit the growth of microorganisms in the product.
SURGX: Sterile Antimicrobial Gel conforms to the postoperative wound. The gel provides a moist wound environment conducive to healing.
Bactisure: Wound Lavage is used to remove debris, including microorganisms, from wounds using pulsed lavage. It is a clear, colourless and low-odour solution.